These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20542069)

  • 1. The broad-spectrum antitumor action of cyclosporin A is due to its tachykinin receptor antagonist pharmacological profile.
    Muñoz M; Rosso M; González A; Saenz J; Coveñas R
    Peptides; 2010 Sep; 31(9):1643-8. PubMed ID: 20542069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines.
    Rosso M; Robles-Frías MJ; Coveñas R; Salinas-Martín MV; Muñoz M
    Tumour Biol; 2008; 29(4):245-54. PubMed ID: 18781096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines.
    Muñoz M; Rosso M; Pérez A; Coveñas R; Rosso R; Zamarriego C; Soult JA; Montero I
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2567-70. PubMed ID: 15980249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138.
    Muñoz M; Rosso M; Coveñas R; Montero I; González-Moles MA; Robles MJ
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2775-81. PubMed ID: 17525212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
    Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
    Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
    González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
    Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines.
    Muñoz M; Rosso M; Pérez A; Coveñas R; Rosso R; Zamarriego C; Piruat JI
    Neuropeptides; 2005 Aug; 39(4):427-32. PubMed ID: 15939468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumoural action of L-733,060 on neuroblastoma and glioma cell lines.
    Muñoz M; Pérez A; Coveñas R; Rosso M; Castro E
    Arch Ital Biol; 2004 Mar; 142(2):105-12. PubMed ID: 15248566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2.
    Muñoz M; Rosso M; Aguilar FJ; González-Moles MA; Redondo M; Esteban F
    Invest New Drugs; 2008 Apr; 26(2):111-8. PubMed ID: 17906845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiproliferative action of [D-Arg(1), D-Phe(5), D-Trp(7,9), LEU(11)] substance P analogue antagonist against small-cell- and non-small-cell lung cancer cells could be due to the pharmacological profile of its tachykinin receptor antagonist.
    Munoz M; Recio S; Rosso M; Redondo M; Covenas R
    J Physiol Pharmacol; 2015 Jun; 66(3):421-6. PubMed ID: 26084224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.
    Muñoz M; Rosso M
    Invest New Drugs; 2010 Apr; 28(2):187-93. PubMed ID: 19148578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK-1 receptor antagonists as antitumor drugs: a survey of the literature from 2000 to 2011.
    Muñoz M; Martinez-Armesto J; Coveñas R
    Expert Opin Ther Pat; 2012 Jul; 22(7):735-46. PubMed ID: 22697287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
    Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Sacco G; Terracciano R; Fincham CI; Sisto A; Evangelista S; Maggi CA; Manzini S
    Neuropeptides; 2001; 35(3-4):137-47. PubMed ID: 11884203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
    Muñoz M; Coveñas R
    Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A.
    Lavagno L; Bordin G; Colangelo D; Viano I; Brunelleschi S
    Neuropeptides; 2001 Apr; 35(2):92-9. PubMed ID: 11384204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.
    Zupanska A; Dziembowska M; Ellert-Miklaszewska A; Gaweda-Walerych K; Kaminska B
    Neurochem Int; 2005 Nov; 47(6):430-41. PubMed ID: 16087277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cyclosporin on cell division and apoptosis in human oral keratinocytes.
    Birraux J; Kirby JA; Thomason JM; Taylor JJ
    J Periodontal Res; 2006 Aug; 41(4):297-302. PubMed ID: 16827723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery.
    Pedersen KE; Buckner CK; Meeker SN; Undem BJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):319-25. PubMed ID: 10604965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines.
    Muñoz M; Rosso M; Robles-Frias MJ; Salinas-Martín MV; Rosso R; González-Ortega A; Coveñas R
    Lab Invest; 2010 Aug; 90(8):1259-69. PubMed ID: 20458280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.